Implementation of the STarT Back Screening Tool

September 12, 2018 updated by: Luciola da Cunha Menezes Costa, Universidade Cidade de Sao Paulo

Implementing the STarT Back Model of Stratifying Care for Patients With Low Back Pain Seeking Care in an Emergency Department: a Prospective Longitudinal Cohort Study

The STarT Back Screening Tool (SBST) has been used in different healthcare settings in order to stratify the management of patients with low back pain. However, to date, no study has investigated the feasibility of implementing the SBST in emergency departments. The objective of this study will be to test the implementation of the SBST in the stratification of patients seeking care in emergency departments.

Study Overview

Status

Unknown

Conditions

Detailed Description

The Start Back Screening Tool (SBST) aims to identify and stratify primary care patients by using modifiable prognostic indicators that are relevant in clinical decision making. The objective of this study will be to test the feasibility of the implementation of the SBST in the stratification of patients seeking care in emergency departments. Study design: A prospective longitudinal cohort study with a 6-month follow-up. Intervention: At 6-weeks after baseline consultation, patients will be targeted to the specific treatment according to their subclassification in the SBST tool: education about pain neurophysiology and physical therapy. This is the first study that will provide results about logistic processes of the implementation of the SBST in the emergency sector, present feasibility data for the conduction of a large randomized controlled trial of subgroups of low back pain.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • We will include patients with back pain seeking care in emergency departments

Exclusion Criteria:

  • We will exclude patients with serious spinal pathologies (such as cancer, fractures, inflammatory and infectious diseases) as well as pregnant patients and patients with nerve root compromise.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: STarT Back Screening Tool Approach
After baseline consultation, all patients will receive usual care from their medical doctors as well as an educational booklet and weekly videos containing information on the prognosis of back pain and how patients could deal with their problems. Six weeks after baseline consultation all patients will be screened by the STarT Back Screening Tool (SBST) and will receive a stratified care according to their SBST classification.
Patients classified as low risk of persistent pain will be educated about their condition and how to manage their back pain by targeting modifiable prognostic factors. Patients classified as medium risk will receive evidence-based physical therapy. Patients classified as high risk will receive evidence-based physical therapy as well as individualized psychological intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility from the perspective of the patient
Time Frame: Adoption at 6 weeks (i.e. at the implementation of treatment after stratification)
Feasibility will be measured by using 4 constructs (Adoption, adequacy, feasibility and fidelity). These constructs will be measured by using yes/no questions.
Adoption at 6 weeks (i.e. at the implementation of treatment after stratification)
Feasibility from the perspective of the patient
Time Frame: Adequacy at 3 months.
Feasibility will be measured by using 4 constructs (Adoption, adequacy, feasibility and fidelity). These constructs will be measured by using yes/no questions.
Adequacy at 3 months.
Feasibility from the perspective of the patient
Time Frame: Fidelity at 3 months.
Feasibility will be measured by using 4 constructs (Adoption, adequacy, feasibility and fidelity). These constructs will be measured by using yes/no questions.
Fidelity at 3 months.
Feasibility from the perspective of the patient
Time Frame: Feasibility at 3 months.
Feasibility will be measured by using 4 constructs (Adoption, adequacy, feasibility and fidelity). These constructs will be measured by using yes/no questions.
Feasibility at 3 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity measured by a 0-10 Pain Numerical Rating Scale
Time Frame: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Pain intensity will be measured by an 11-point (0-10) Pain Numerical Rating Scale (Pain NRS). Higher scores indicates higher pain intensity.
1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Disability measured by the 0-24 Roland Morris Disability Questionnaire
Time Frame: 6 weeks and 3 and 6 months after first consultation at the emergency department.
Disability will be measured by the 24-item Roland Morris Disability Questionnaire. Higher scores indicates higher disability.
6 weeks and 3 and 6 months after first consultation at the emergency department.
Risk of persistent disability measured by the 0-9 Start Back Screening Tool.
Time Frame: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Risk of persistent disability will be measured using the 0-9 point Start Back Screening Tool. The higher the score the higher is the risk of persistent disability.
1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Global Impression of Recovery measured by the -5 to + 5 Global Perceived Effect Scale.
Time Frame: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Global Impression of Recovery will be measured using the 11-item Global Perceived Effect Scale. Positive values represents recovery and negative values represents deterioration of symptoms.
1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Recovery from pain
Time Frame: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Recovery from pain will be measured using a yes/no question (i.e. Were you completely free of back pain over the last month?)
1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Depressive symptoms over the last week.
Time Frame: 1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Depression will be measured by a single question on how depressed patients were over the last week (measured on a 0-10 likert scale)
1, 2, 6 weeks and 3 and 6 months after first consultation at the emergency department.
Recurrence of low back pain symptoms
Time Frame: 6 weeks and 3 and 6 months after first consultation at the emergency department.
Patients who recovered will be asked if they have experience a recurrence of symptoms
6 weeks and 3 and 6 months after first consultation at the emergency department.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Out of pocket costs associated with low back pain
Time Frame: 6 weeks and 3 and 6 months after first consultation at the emergency department.
Out of pocket costs will be measured using a 9-dimension cost diary
6 weeks and 3 and 6 months after first consultation at the emergency department.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luciola Costa, PhD, Universidade Cidade de Sao Paulo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2018

Primary Completion (Anticipated)

October 1, 2019

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

September 5, 2018

First Submitted That Met QC Criteria

September 12, 2018

First Posted (Actual)

September 14, 2018

Study Record Updates

Last Update Posted (Actual)

September 14, 2018

Last Update Submitted That Met QC Criteria

September 12, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Unicid20

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

We can share our dataset upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on STarT Back Screening Tool Approach

Subscribe